John F DiPersio Selected Research

Diarrhea

1/2017	Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial.
12/2013	Safety and efficacy of upfront plerixafor + G-CSF versus placebo + G-CSF for mobilization of CD34(+) hematopoietic progenitor cells in patients ≥60 and <60 years of age with non-Hodgkin's lymphoma or multiple myeloma.
4/2003	Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients: a case-control study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John F DiPersio Research Topics

Disease

52	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2024 - 11/2003
51	Neoplasms (Cancer) 01/2024 - 07/2002
32	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2024 - 04/2003
25	Leukemia 01/2023 - 07/2002
25	Multiple Myeloma 01/2023 - 03/2004
19	Hematologic Neoplasms (Hematological Malignancy) 04/2024 - 12/2003
18	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 07/2006
11	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2019 - 03/2004
8	Infections 10/2023 - 04/2003
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022 - 04/2008
6	Disease Progression 09/2018 - 02/2010
6	Primary Myelofibrosis (Myelosclerosis) 01/2017 - 03/2012
5	Bronchiolitis Obliterans Syndrome 12/2023 - 04/2017
5	Lymphoma (Lymphomas) 11/2020 - 10/2006
5	Acute Promyelocytic Leukemia 01/2019 - 07/2002
4	Cytokine Release Syndrome 10/2023 - 10/2016
4	Injection Site Reaction 12/2013 - 06/2009
3	Inflammation (Inflammations) 01/2022 - 10/2020
3	Thrombocytopenia (Thrombopenia) 01/2020 - 03/2012
3	Residual Neoplasm 01/2017 - 07/2002
3	Diarrhea 01/2017 - 04/2003
3	Splenomegaly 01/2017 - 02/2014
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2014 - 11/2003
2	Pneumonia (Pneumonitis) 11/2023 - 01/2017
2	COVID-19 11/2023 - 01/2022
2	cell-associated neurotoxicity 10/2023 - 01/2023
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2023 - 01/2012
2	Sepsis (Septicemia) 10/2023 - 01/2017
2	Aplastic Anemia (Anemia, Hypoplastic) 10/2023 - 10/2006
2	Sickle Cell Anemia (Hemoglobin S Disease) 01/2023 - 07/2014
2	Philadelphia Chromosome 11/2022 - 04/2008
2	Hematologic Diseases (Blood Diseases) 01/2022 - 12/2021
2	B-Cell Lymphoma (Lymphoma, B Cell) 12/2019 - 12/2019
2	Breast Neoplasms (Breast Cancer) 01/2018 - 01/2016
2	Myeloid Leukemia (Leukemia, Myelocytic) 04/2017 - 01/2014
2	Fatigue 01/2017 - 12/2013
2	Chromosome Aberrations (Chromosome Abnormalities) 11/2016 - 02/2015
2	Viremia 11/2016 - 03/2003
2	Anemia 04/2015 - 03/2012
2	Mucositis 01/2014 - 04/2003

Drug/Important Bio-Agent (IBA)

18	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2023 - 03/2003
16	plerixafor FDA Link 01/2021 - 03/2004
12	ruxolitinibIBA 12/2023 - 03/2012
10	Chimeric Antigen ReceptorsIBA 10/2023 - 01/2019
8	Decitabine FDA Link 01/2023 - 02/2010
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 07/2006
6	CytokinesIBA 11/2023 - 11/2020
6	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2015
6	DNA (Deoxyribonucleic Acid)IBA 12/2014 - 11/2003
5	Janus KinasesIBA 01/2023 - 03/2012
5	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2022 - 01/2012
4	Janus Kinase InhibitorsIBA 04/2024 - 05/2013
4	RNA (Ribonucleic Acid)IBA 11/2023 - 01/2021
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2013
3	efineptakin alfaIBA 12/2023 - 01/2022
3	Interleukin-7 (Interleukin 7)IBA 10/2023 - 01/2022
3	Interferon gamma ReceptorIBA 01/2023 - 01/2014
3	SteroidsIBA 01/2022 - 01/2016
3	Azacitidine (5 Azacytidine)FDA Link 11/2021 - 01/2017
3	Bortezomib (Velcade)FDA Link 11/2020 - 11/2007
3	tisagenlecleucelIBA 12/2019 - 01/2019
3	Lenalidomide (CC 5013)FDA Link 01/2018 - 02/2011
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2012 - 04/2008
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2023 - 10/2023
2	Transcription Factors (Transcription Factor)IBA 11/2023 - 01/2023
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2023 - 07/2006
2	InterleukinsIBA 10/2023 - 01/2016
2	Methotrexate (Mexate)FDA LinkGeneric 11/2022 - 07/2006
2	EpitopesIBA 10/2022 - 01/2020
2	Small Cytoplasmic RNAIBA 10/2022 - 01/2022
2	ALT-803IBA 01/2022 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2021
2	Interleukin-15 (Interleukin 15)IBA 01/2022 - 11/2020
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 09/2010
2	baricitinibIBA 12/2021 - 11/2018
2	IntegrinsIBA 11/2020 - 04/2016
2	Cladribine FDA LinkGeneric 01/2020 - 08/2009
2	Filgrastim (Neupogen)FDA Link 01/2020 - 12/2017
2	Rituximab (Mabthera)FDA Link 12/2019 - 01/2018
2	RadiopharmaceuticalsIBA 01/2018 - 04/2016
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2018 - 08/2017
2	AntibodiesIBA 04/2016 - 01/2016
2	Ganciclovir (Cytovene)FDA LinkGeneric 06/2015 - 07/2003
2	Phosphotransferases (Kinase)IBA 06/2015 - 05/2008
2	Janus Kinase 1IBA 04/2015 - 12/2013
2	Vorinostat FDA Link 01/2014 - 10/2009

Therapy/Procedure

48	Therapeutics 12/2023 - 07/2002
31	Cell Transplantation 04/2024 - 01/2014
24	Drug Therapy (Chemotherapy) 10/2023 - 07/2002
18	Immunotherapy 01/2023 - 08/2017
18	Transplantation 01/2023 - 03/2003
15	Hematopoietic Stem Cell Transplantation 01/2023 - 10/2006
11	Stem Cell Transplantation 10/2023 - 07/2004
5	Hematopoietic Stem Cell Mobilization 10/2019 - 10/2009
3	Autologous Transplantation 01/2023 - 11/2007
3	Homologous Transplantation 12/2018 - 07/2006
2	Aftercare (After-Treatment) 01/2023 - 12/2019
2	Radiotherapy 11/2022 - 02/2015
2	Organ Transplantation 12/2021 - 01/2020
2	Blood Component Removal (Apheresis) 11/2019 - 10/2009